Abstract
Recent evidence indicates that toxigenic Clostridium difficile strains are a major cause of antimicrobial-associated ileocecitis in laboratory animals and pseudomembranous colitis in humans. C. difficile ATCC 9689 was cultivated in a synthetic medium to which 3% ultrafiltrated proteose peptone was added. Purification of the toxin from broth filtrate was accomplished through ultrafiltration (100,000 nominal-molecular-weight-limit membrane), precipitation with 75% (NH4)2SO4, and chromatographic separation using Bio-Gel A 5m followed by ion-exchange chromatography on a diethylaminoethyl-Sephadex A-25 column. The purified toxin displayed only one band on polyacrylamide gel electrophoresis, and approximately 170 pg was cytopathic for human amnion cells. The isolated toxin was neutralized by Clostridium sordelli antitoxin, heat labile (56 degrees C for 30 min), and inactivated at pH 4 and 9; it had an isoelectric point of 5.0, increased vascular permeability in rabbits, and caused ileocecitis in hamsters when injected intracecally. Treatment of the toxin with trypsin, chymotrypsin, pronase, amylase, or ethylmercurithiosalicylate caused inactivation, whereas lipase had no effect. By gel filtration, its molecular weight was estimated as 530,000. Upon reduction and denaturation, the toxin dissociated into 185,000- and 50,000-molecular-weight components, as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Extensive dissociation yielded only the 50,000-molecular-weight component. The toxin appears to be protoplasmic and is released into the surrounding environment upon autolysis of the cells. Attempts to correlate specific enzymatic activity with the toxin have been unsuccessful. These studies will help delineate the role of C. difficile toxin in antimicrobial-associated colitis and diarrhea.
Full text
PDF










Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Andrews P. The gel-filtration behaviour of proteins related to their molecular weights over a wide range. Biochem J. 1965 Sep;96(3):595–606. doi: 10.1042/bj0960595. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bartlett J. G., Chang T. W., Gurwith M., Gorbach S. L., Onderdonk A. B. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med. 1978 Mar 9;298(10):531–534. doi: 10.1056/NEJM197803092981003. [DOI] [PubMed] [Google Scholar]
- Bartlett J. G., Gorbach S. L. Pseudomembranous enterocolitis (antibiotic-related colitis). Adv Intern Med. 1977;22:455–476. [PubMed] [Google Scholar]
- Bartlett J. G., Moon N., Chang T. W., Taylor N., Onderdonk A. B. Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis. Gastroenterology. 1978 Nov;75(5):778–782. [PubMed] [Google Scholar]
- Bartlett J. G., Onderdonk A. B., Cisneros R. L., Kasper D. L. Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. J Infect Dis. 1977 Nov;136(5):701–705. doi: 10.1093/infdis/136.5.701. [DOI] [PubMed] [Google Scholar]
- Cameron A., Thomas M. Pseudomembranous colitis and co-trimoxazole. Br Med J. 1977 May 21;1(6072):1321–1321. doi: 10.1136/bmj.1.6072.1321. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chang T. W., Bartlett J. G., Gorbach S. L., Onderdonk A. B. Clindamycin-induced enterocolitis in hamsters as a model of pseudomembranous colitis in patients. Infect Immun. 1978 May;20(2):526–529. doi: 10.1128/iai.20.2.526-529.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chang T. W., Onderdonk A. B., Bartlett J. G. Anion-exchange resins in antibiotic-associated colitis. Lancet. 1978 Jul 29;2(8083):258–259. doi: 10.1016/s0140-6736(78)91765-8. [DOI] [PubMed] [Google Scholar]
- DAVIS B. J. DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS. Ann N Y Acad Sci. 1964 Dec 28;121:404–427. doi: 10.1111/j.1749-6632.1964.tb14213.x. [DOI] [PubMed] [Google Scholar]
- Duncan C. L., Strong D. H., Sebald M. Sporulation and enterotoxin production by mutants of Clostridium perfringens. J Bacteriol. 1972 Apr;110(1):378–391. doi: 10.1128/jb.110.1.378-391.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ericsson C. D., Evans D. G., DuPont H. L., Evans D. J., Jr, Pickering L. K. Bismuth subsalicylate inhibits activity of crude toxins of Escherichia coli and Vibrio cholerae. J Infect Dis. 1977 Nov;136(5):693–696. doi: 10.1093/infdis/136.5.693. [DOI] [PubMed] [Google Scholar]
- Evans D. J., Jr, Evans D. G., Gorbach S. L. Production of vascular permeability factor by enterotoxigenic Escherichia coli isolated from man. Infect Immun. 1973 Nov;8(5):725–730. doi: 10.1128/iai.8.5.725-730.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
- George R. H., Symonds J. M., Dimock F., Brown J. D., Arabi Y., Shinagawa N., Keighley M. R., Alexander-Williams J., Burdon D. W. Identification of Clostridium difficile as a cause of pseudomembranous colitis. Br Med J. 1978 Mar 18;1(6114):695–695. doi: 10.1136/bmj.1.6114.695. [DOI] [PMC free article] [PubMed] [Google Scholar]
- George R. H., Youngs D. J., Johnson E. M., Burdon D. W. Anion-exchange resins in pseudomembranous colitis. Lancet. 1978 Sep 16;2(8090):624–624. doi: 10.1016/s0140-6736(78)92840-4. [DOI] [PubMed] [Google Scholar]
- George W. L., Sutter V. L., Finegold S. M. Antimicrobial agent-induced diarrhea--a bacterial disease. J Infect Dis. 1977 Dec;136(6):822–828. doi: 10.1093/infdis/136.6.822. [DOI] [PubMed] [Google Scholar]
- Gorbach S. L., Bartlett J. G. Pseudomembranous enterocolitis: a review of its diverse forms. J Infect Dis. 1977 Mar;135 (Suppl):S89–S94. doi: 10.1093/infdis/135.supplement.s89. [DOI] [PubMed] [Google Scholar]
- Gurwith M. J., Rabin H. R., Love K. Diarrhea associated with clindamycin and ampicillin therapy: preliminary results of a cooperative study. J Infect Dis. 1977 Mar;135 (Suppl):S104–S110. doi: 10.1093/infdis/135.supplement.s104. [DOI] [PubMed] [Google Scholar]
- HJERTEN S. "Molecular sieve" chromatography on polyacrylamide gels, prepared according to a simplified method. Arch Biochem Biophys. 1962 Sep;Suppl 1:147–151. [PubMed] [Google Scholar]
- JEFFRIES C. D., HOLTMAN D. F., GUSE D. G. Rapid method for determining the activity of microorganisms on nucleic acids. J Bacteriol. 1957 Apr;73(4):590–591. doi: 10.1128/jb.73.4.590-591.1957. [DOI] [PMC free article] [PubMed] [Google Scholar]
- KALNITSKY G., HUMMEL J. P., DIERKS C. [Some factors which affect the enzymatic digestion of ribonucleic acid]. J Biol Chem. 1959 Jun;234(6):1512–1516. [PubMed] [Google Scholar]
- KUNITZ M. Crystalline desoxyribonuclease; isolation and general properties; spectrophotometric method for the measurement of desoxyribonuclease activity. J Gen Physiol. 1950 Mar;33(4):349–362. doi: 10.1085/jgp.33.4.349. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Keating J. P., Frank A. L., Barton L. L., Tedesco F. J. Pseudomembranous colitis associated with ampicillin therapy. Am J Dis Child. 1974 Sep;128(3):369–370. doi: 10.1001/archpedi.1974.02110280099014. [DOI] [PubMed] [Google Scholar]
- Keighley M. R., Burdon D. W., Arabi Y., Williams J. A., Thompson H., Youngs D., Johnson M., Bentley S., George R. H., Mogg G. A. Randomised controlled trial of vancomycin for pseudomembranous colitis and postoperative diarrhoea. Br Med J. 1978 Dec 16;2(6153):1667–1669. doi: 10.1136/bmj.2.6153.1667. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Keusch G. T., Present D. H. Summary of a workshop on clindamycin colitis. J Infect Dis. 1976 May;133(5):578–587. doi: 10.1093/infdis/133.5.578. [DOI] [PubMed] [Google Scholar]
- Kreutzer E. W., Milligan F. D. Treatment of antibiotic-associated pseudomembranous colitis with cholestyramine resin. Johns Hopkins Med J. 1978 Sep;143(3):67–72. [PubMed] [Google Scholar]
- LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
- Larson H. E., Parry J. V., Price A. B., Davies D. R., Dolby J., Tyrrell D. A. Undescribed toxin in pseudomembranous colitis. Br Med J. 1977 May 14;1(6071):1246–1248. doi: 10.1136/bmj.1.6071.1246. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Larson H. E., Price A. B. Pseudomembranous colitis: Presence of clostridial toxin. Lancet. 1977 Dec 24;2(8052-8053):1312–1314. doi: 10.1016/s0140-6736(77)90363-4. [DOI] [PubMed] [Google Scholar]
- Le Frock J. L., Klainer A. S., Chen S., Gainer R. B., Omar M., Anderson W. The spectrum of colitis associated with lincomycin and clindamycin therapy. J Infect Dis. 1975 May;131 (Suppl):S108–S115. doi: 10.1093/infdis/131.supplement.s108. [DOI] [PubMed] [Google Scholar]
- Ledger W. J., Puttler O. L. Death from pseudomembranous enterocolitis. Obstet Gynecol. 1975 Jun;45(6):609–613. doi: 10.1097/00006250-197506000-00002. [DOI] [PubMed] [Google Scholar]
- Lusk R. H., Fekety F. R., Jr, Silva J., Jr, Bodendorfer T., Devine B. J., Kawanishi H., Korff L., Nakauchi D., Rogers S., Siskin S. B. Gastrointestinal side effects of clindamycin and ampicillin therapy. J Infect Dis. 1977 Mar;135 (Suppl):S111–S119. doi: 10.1093/infdis/135.supplement.s111. [DOI] [PubMed] [Google Scholar]
- Madsen G. L., Knoop F. C. Inhibition of the secretory activity of Escherichia coli heat-stable enterotoxin by indomethacin. Infect Immun. 1978 Oct;22(1):143–147. doi: 10.1128/iai.22.1.143-147.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Marrie T. J., Faulkner R. S., Badley B. W., Hartlen M. R., Comeau S. A., Miller H. R. Pseudomembranous colitis: isolation of two species of cytotoxic clostridia and successful treatment with vancomycin. Can Med Assoc J. 1978 Nov 4;119(9):1058–1060. [PMC free article] [PubMed] [Google Scholar]
- Neu H. C., Prince A., Neu C. O., Garvey G. J. Incidence of diarrhea and colitis associated with clindamycin therapy. J Infect Dis. 1977 Mar;135 (Suppl):S120–S125. doi: 10.1093/infdis/135.supplement.s120. [DOI] [PubMed] [Google Scholar]
- Ohgke H., Wagner D. Hitzestabiles Escherichia coli-Enterotoxin: Wirkungsminderung durch Phenylbutazon. Zentralbl Bakteriol Orig A. 1977 Jul;238(3):350–354. [PubMed] [Google Scholar]
- Pittman F. E., Pittman J. C., Humphrey C. D. Colitis following oral lincomycin therapy. Arch Intern Med. 1974 Aug;134(2):368–372. [PubMed] [Google Scholar]
- Rifkin G. D., Fekety F. R., Silva J., Jr Antibiotic-induced colitis implication of a toxin neutralised by Clostridium sordellii antitoxin. Lancet. 1977 Nov 26;2(8048):1103–1106. doi: 10.1016/s0140-6736(77)90547-5. [DOI] [PubMed] [Google Scholar]
- Smith P. B., Hancock G. A., Rhoden D. L. Improved medium for detecting deoxyribonuclease-producing bacteria. Appl Microbiol. 1969 Dec;18(6):991–993. doi: 10.1128/am.18.6.991-993.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stark R. L., Duncan C. L. Biological characteristics of Clostridium perfringens type A enterotoxin. Infect Immun. 1971 Aug;4(2):89–96. doi: 10.1128/iai.4.2.89-96.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Varel V. H., Bryant M. P. Nutritional features of Bacteroides fragilis subsp. fragilis. Appl Microbiol. 1974 Aug;28(2):251–257. doi: 10.1128/am.28.2.251-257.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Viteri A. L., Howard P. H., Dyck W. P. The spectrum of lincomycin-clindamycin colitis. Gastroenterology. 1974 Jun;66(6):1137–1144. [PubMed] [Google Scholar]
- Weber K., Osborn M. The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. J Biol Chem. 1969 Aug 25;244(16):4406–4412. [PubMed] [Google Scholar]